EOSPA provides fractional product development and CMC leadership to emerging and growth-stage biotech companies.

We operate at the intersection of strategy, execution, and decision-making under uncertainty- where programs often succeed or fail. From IND-enabling through clinical execution, we partner with teams to bring structure to complexity, align cross-functional efforts, and ensure programs move forward with clarity and discipline.

Our approach is hands-on and integrated. We work alongside our clients to identify risks early, drive alignment across functions, and translate strategy into execution- helping ensure programs not only progress, but hold up in real-world development and at scale.

In parallel, EOSPA provides technology and data solutions that support complex, regulated environments- including biotech, healthcare, and federal clients. These capabilities include enterprise systems, data architecture, and digital infrastructure that enable scalable, compliant, and execution-ready operations.

This combination of product development leadership and enabling technology allows EOSPA to support both the strategic and operational backbone of modern biotech programs.

Based in the Washington, DC area, EOSPA supports clients across the U.S. and globally.